overnight fast and were processed, immediately refrigerated, and transported in cold storage to the Central Testing Institute in Seoul, Korea. Analysis of all blood samples was performed within 24 h after transportation. Measurements of the concentration of glucose, high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and triglycerides were performed using a Hitachi automatic analyzer 7600 (Tokyo, Japan). Immunoradiometric assay using a 1470 WIZARD gamma-counter (PerkinElmer, Finland) was used for measurement of insulin. Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated using the following formula: HOMA-IR=fasting plasma glucose (mg/dL) × fasting insulin (μIU/mL)/405 [21] . Obesity was defined as a body mass index 27.5 kg/m 2 , the cutoff associated with increased mortality rates in Asians, including Koreans [22, 23] . Waist circumference was measured at the mid-point between the lower margin of the last palpable rib and the top of the iliac crest at the end of a normal expiration with the arms relaxed at the sides. According to the National Cholesterol Education Program Adult Treatment Panel III criteria [24] and the Korean abdominal obesity criteria for waist circumference [25] , subjects were classified as having MS if they had any three of the following five characteristics: central obesity (waist circumference ≥ 90 cm in men and ≥ 85 cm in women), hypertriglyceridemia (triglycerides ≥150 mg/dL or triglyceride-lowering medication), HDL cholesterol (<40 mg/dL in males or <50mg/dL in females), hypertension (≥130 mmHg systolic or ≥85 mmHg diastolic pressure, or use of antihypertensive medication), dysglycemia (fasting plasma glucose ≥100 mg/dL or use of anti-hyperglycemic medication, or previously diagnosed type 2 diabetes). The study was approved by the Institutional Review Board of the Korea Center for Disease Control and prevention (2012-01EXP-01-2C).
Definition of sarcopenia
Dual energy X-ray absorptiometry (DXA) (Discovery-W; Hologic, Waltham, MA,USA) was used for measurement of appendicular skeletal muscle mass (ASM) [26] . Sarcopenia was defined as ASM divided by body weight (ASM/Wt) (%) more than two standard deviations (SD) below mean value of sex-specific normal young people [27, 28] . The definition was modified from the studies of Janssen et al. [29] . The sex-specific young reference group included 3343 healthy adults aged 20-40 yr (1449 men, 1894 women). As cutoff points, among members of the elderly population. Total lean body mass shows a decline after the age of 45, however, onset of the decline in total lean body mass percentage of total body mass can be detected as early as the third decade; therefore, among younger members of the population, there must be some individuals with sarcopenia [14] . However, etiology of sarcopenia could differ among age groups. Muscle type II fibers, which are less sensitive to insulin than type I fibers, have shown greater vulnerability to atrophy with aging than type I fibers [15, 16] . In addition, the relationship of sarcopenia to insulin resistance or pre-diabetes has been suggested to differ according to age and coexistence of obesity [17] .
To the best of our knowledge, no study of the association of sarcopenia with insulin resistance, diabetes, and metabolic syndrome according to age group and obesity status in the general population has been reported. In order to elucidate these relationships, we investigated the relationship of sarcopenia with insulin resistance, diabetes, and metabolic syndrome in the Korean population based on the Korea National Health and Nutrition Examination Survey conducted in 2009 and 2010.
Subjects and Methods

Study population
This study was based on data acquired during the third year (2009) of the Korea National Health and Nutrition Examination Survey (KNHANES) IV (2007) (2008) (2009) ) and the first year (2010) of KNHANES V (2010-2012). These surveys have been conducted periodically since 1998, using a rolling sampling design involving a complex, stratified, multistage, probability-cluster survey of a representative sample of the non-institutionalized civilian population in order to assess the health and nutritional status of the Korean population [18] [19] [20] . The survey, which was conducted by the Korean Ministry of Health and Welfare, consists of the health interview survey, the health examination survey, and the nutrition survey. These surveys were completed by 10,078 (79.2% of the total target population of 12,722) participants and 8473 (77.5% of the total target population of 10.938) participants in 2009 and 2010, respectively. The current cross-sectional study was restricted to participants who were ≥ 20 years of age who completed the health examination survey, including whole body DXA (n=10432). During conduct of the survey, blood samples were collected from each participant in the morning following an
Results
Insulin resistance according to the category of sarcopenia and obesity
The baseline characteristics according to sarcopenic status are shown in Table 1 . Among sarcopenic participants, compared with nonsarcopenic participants, higher HOMA-IR was observed only in the non-obese group (P<0.001). While sarcopenic subjects had a higher HOMA-IR than those without sarcopenia in 40-59 years and ≥60 years age group of the non-obese group (P=0.002 and <0.001, respectively), after adjustment for age, sex, region, smoking, alcohol consumption, exercise, and family income, the 20-39 years age group showed the tendency without significance (2.20 ± 1.07 vs. 1.98 ± 1.01, among sarcopenic and nonsarcopenic subjects, respectively, P=0.144). Subjects in the obese group did not show that tendency (P=0.238) ( Table 2 ).
Prevalence of diabetes according to the category of sarcopenia and obesity
Prevalence of diabetes was higher among sarcopenic participants than among nonsarcopenic participants only in the non-obese group (23.1% vs. 7.8%, P<0.001). Sarcopenic subjects had a higher prevalence of diabetes than those without sarcopenia only in ≥60 years age group of the non-obese group (OR=2.448; 95%CI, 1.695-3.538; P<0.001). No significant association was observed between diabetes and sarcopenia in other age groups ( Table 3) .
Prevalence of MS according to the category of sarcopenia and obesity after stratification
Prevalence of MS was higher among sarcopenic subjects, compared to nonsarcopenic subjects in the non-obese group (OR=2.209; 95%CI, 1.679-2.906; P<0.001), however, that relationship was not observed in the obese group. After stratification according to age, sex, region, smoking, alcohol drinking, regular exercise, and family income, MS was found to be more prevalent among nonobese and sarcopenic participants in every subgroup except the 20-39 years age group and the 75th-100th family income group, compared with nonobese and nonsarcopenic subjects after adjustment for confounding variables ( Table 4) .
Association of sarcopenia with individual components of MS in non-obese participants
When we attempted to determine which individual the two SDs of sex-specific normal young people were 26.98% in men and 21.14% in women, respectively. All participants in this survey signed an informed consent form.
Statistical analyses
Levels of HOMA-IR were log-transformed because their distributions were positively skewed. Geometric means with standard errors of HOMA-IR were calculated using analysis of covariance (ANCOVA) after adjustment for age, sex, region, smoking, alcohol consumption, regular exercise, and family income. Age was categorized according to three groups (20-39 years, 40-59 years, and ≥60 years). Logistic regression models were used for calculation of multivariate-adjusted odds ratios (ORs). Adjusted variables included age, sex, region, smoking, alcohol consumption, regular exercise, and family income. Subgroup analyses stratified according to age, sex, region, smoking, alcohol drinking, regular exercise, and family income were performed. Region was categorized as rural and urban. Among the 16 administrative districts where this survey was conducted, Seoul, Gyeonggi, and six other metropolitan cities (Busan, Daegu, Incheon, Gwangju, Daejeon, and Ulsan) were grouped as urban areas. The remaining regions were grouped as rural areas. Smoking status was divided into three categories: never, former, and current smoker. Alcohol consumption was indicated as 'yes' for participants who consumed at least two units of alcohol every week over the last year. Regular exercise was indicated as 'yes' when the participant performed moderate or strenuous exercise on a regular basis, regardless of indoor or outdoor exercise (for more than 30 min at a time and more than five times per week in the case of moderate exercise, such as swimming slowly, tennis doubles, volleyball, badminton, table tennis, and carrying light objects; for more than 20 min at a time in the case of strenuous exercise, such as running, climbing, cycling fast, swimming fast, football, basketball, jump rope, squash, tennis singles, and carrying heavy objects or when subject walked for more than 30 min at a time and more than five times per week. Family income was categorized into four groups according to quartile. All tests were two-sided, and P<0.05 was considered statistically significant. Statistical Package for Social Science 15.0 software (SPSS, Chicago, IL, USA) was used in performance of all analyses. Alcohol consumption was indicated as 'yes' for participants who consumed at least two units of alcohol every week over the last year. f Regular exercise was indicated as 'yes' when the participant performedmoderate or strenuous exercise on a regular basis (for more than 30 min at a time and more than five times per week in the case of moderate exercise; for more than 20 min at a time in the case of strenuous exercise) or when the subject walked for more than 30 min at a time and more than five times per week. 
Insulin resistance and prevalence of diabetes and MS according to the category of sarcopenia and obesity in the elderly
To show the data of the elderly, age was categorized according to three groups (60-69, 70-79, and ≥ 80 years). While sarcopenic subjects had higher HOMA-IR and prevalence of diabetes and MS than those without sarcopenia in the non-obese group, after adjustment for age, sex, region, smoking, alcohol consumption, exercise, and family income, subjects in the obese group did not show that tendency. Among sarcopenic particicomponent of MS is involved in the significant relationship between sarcopenia and MS in the non-obese group, hypertension, elevated TG, and central obesity were found to have a significant relationship with sarcopenia. In ≥60 years age subgroup of the non-obese group, prevalence of hypertension, elevated TG, dysglycemia (FPG ≥ 100 mg/dl or on diabetes treatment), and central obesity was higher among sarcopenic subjects than among those without sarcopenia. In contrast, subjects in the obese group did not show that tendency (Table 5) . alent among sarcopenic subjects than among those without sarcopenia. All of these findings were applicable particularly to ≥60 years age subgroup. Taken together, our findings indicated that, regarding metabolic disorders, including insulin resistance, diabetes, and MS, non-obese elderly people in the Korean population, compared with obese elderly people, are more affected by sarcopenia. Because people in Asia tend to develop type 2 diabetes with less degree of obesity [30] , these facts are worthy of notice. Although several studies have suggested that insulin resistance and MS are increased synergistically by sarcopenia and obesity [17, 27, 31, 32] , the interaction of sarcopenia and obesity in dysglycemia and MS has been inconsistent among previously published studies. One study reported an association of sarcopenia with dysglycemia in obese individuals but not in non-obese individuals [17] . On the contrary, in obese postmenopausal women, sarcopenia showed an association with a better lipid profile and lower CVD predisposing factors [33] . In the New Mexico Aging Process Study, the pants, compared with nonsarcopenic participants, higher HOMA-IR was observed in the 70-79 years age group (P=0.005), higher prevalence of diabetes was shown in the 60-69 and 70-79 years age groups (P=0.001 and P<0.001, respectively), and MS was more prevalent in the three age groups(P=0.002, P<0.001, and P=0.041, respectively) (Supplemental Table 1 ).
Discussion
Thus far, obesity has been regarded as the most crucial underlying cause of insulin resistance leading to type 2 diabetes and MS. Of note, results of this study demonstrated that sarcopenia may be an early predictor for insulin resistance, diabetes, and MS, even without coexistence of obesity. Sarcopenia showed a significant association with insulin resistance in the nonobese group, but not in the obese group. Sarcopenia was also found to be a risk factor for MS in the nonobese group, but not in the obese-group. In addition, only in the non-obese group, diabetes was more prev- to be more prevalent among sarcopenic subjects only in the non-obese group. Obesity is known to be the most important underlying cause of insulin resistance, which is an underlying mechanism for type 2 diabetes and MS. Although sarcopenia may also result in insulin resistance, the effect of sarcopenia is weaker compared with obesity. In the previous studies, obesity without sarcopenia has shown the higher HOMA-IR than sarcopenia without obesity [17, 27] . In obese subjects, there is greater lipid content within skeletal muscle [35] , which may already diminish insulin sensitivity in muscle [36] . Therefore, in that case, sarcopenia may not be a critical determinant for insulin resistance or MS. Therefore we assumed that the pathogenetic mechanism of sarcopenia may differ between in obese individuals and in those without obesity.
No study investigating the association of sarcopenia with insulin resistance or MS specifically in the young age group has been reported, although some studies included subjects who were 20 years of age or older prevalence of MS was higher in the non-sacrcopenic obese group than the sarcopenic obese group [34] . The current study showed an additive effect of sarcopenia and obesity on insulin resistance and diabetes, although the effect of sarcopenia on HOMA-IR, MS, and diabetes was insignificant in the obese group. The sarcopenic and obese group showed higher HOMA-IR than either the sarcopenic group or the obese group alone (3.15±1.04, 2.32±1.03, and 3.02±1.02, respectively), the prevalence of diabetes in the sarcopenic and obese group was higher than either in the sarcopenic or in the obese group alone (28.0, 23.1, and 15.2 %, respectively). The discrepancy between studies may be, at least in part, due to study design and population characteristics.
Results of the current study showed that non-obese individuals were more affected by sacrcopenia with regard to insulin resistance, and sarcopenia showed a significant association with MS in the non-obese group, but not in the obese group. Diabetes was found area, and the HOMA-IR, could underestimate sarcopenia in overweight or obese subjects [27] . This study has several limitations. First, we could not differentiate type 1 from type 2 diabetes from the KNHANES dataset. Although we selected participants who were older than 20 years of age and prevalence of type 1 diabetes is relatively low in Korea, we could not exclude the possibility that participants with type 1 diabetes were included in this study. Therefore, there could be selection bias. Second, although we restricted the study population to participants without diagnosed diabetes in order to exclude the effect of diabetes on sarcopenia in certain analyses, the crosssectional study design prevented us from affirming the causal relationship between sarcopenia and insulin resistance, diabetes, and MS. Their causal relationship should be verified in future longitudinal studies. Finally, it was recently suggested that the definition of sarcopenia be restricted to the presence of low muscle strength or poor physical performance in addition to reduced muscle, therefore, because we did not measure muscle strength for determination of sarcopenia; this might also have been a limitation Despite these limitations, because the population of the current study was representative of the general Korean population, this study has powerful strength. In conclusion, results of this study showed a greater association of sarcopenia with increased insulin resistance and prevalence of diabetes and MS among non-obese participants. Of particular interest, in non-obese elderly people, sarcopenia was found to be a significant correlate of those metabolic disorders. Therefore, sarcopenia may be a significant predictor of type 2 diabetes and MS susceptibility in non-obese elderly population.
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in their study population [17, 37] . One study reported a stronger association of sarcopenia with dysglycemia in individuals younger than 60 years of age, compared with those older than 60 years [17] , which is somewhat incompatible with the result of the current study, which did not show a significant association between dysglycemia among metabolic syndrome components with sarcopenia. The age difference in the metabolic effect of sarcopenia is probably due to the result of differences in the etiology of sarcopenia in the young age group, compared with the elderly group. Elderly sarcopenic individuals have more decreased type II muscle fibers, which are less sensitive to insulin action [38, 39] , while sarcopenia in younger individuals is caused primarily by reduced accumulation of skeletal muscle mass not by muscle atrophy. Thus, sarcopenia of older individuals could mean increased insulin sensitivity and improved glucose disposal by insulin.
However, in the current study, we did not observe improved insulin resistance in older participants. In contrast, insulin resistance and prevalence of diabetes and MS were higher among sarcopenic individuals than among non-sarcopenic individuals in the elderly group (≥60 years). In this study, sarcopenia of older participants, even among non-obese subjects, did not mean increased insulin sensitivity. We did not examine the muscle type of individual participants; therefore, we cannot explain the definite reasons for the discrepancy. We assume that, with regard to metabolic derangements, sarcopenia has the same harmful meaning to elderly subjects as young people. In the current study, the 20-39 years age group showed no significant relationships of sarcopenia with insulin resistance, diabetes, and MS after an adjustment for confounding factors. The prevalence of sarcopenia in the non-obese young age group was very low as 0.009% in this study, which is inferred as a reason for the insignificant result. The 40-59 years age group showed significant relationships of sarcopenia with insulin resistance and MS but not with diabetes. It seems that sarcopenia becomes more prevalent and more affects metabolic disorders according to aging. However, it remains to be clarified in the future study. We adopted ASM divided by body weight (%) as a skeletal muscle mass index to define sarcopenia, since that ASM/Wt has been widely adopted in many studies to define sarcopenia and that ASM/Wt was suggested to be the more appropriate index for sarcopenic obesity in the Korean population, because ASM/height(m)2, which was positively correlated with BMI, visceral fat 
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